These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27002089)

  • 1. Letter by Aquaro et al Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".
    Aquaro GD; Todiere G; Barison A
    Circulation; 2016 Mar; 133(12):e448. PubMed ID: 27002089
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Cohen and Maurer Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".
    Cohen LP; Maurer MS
    Circulation; 2016 Mar; 133(12):e449. PubMed ID: 27002090
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Letters Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".
    Fontana M; Pica S; Reant P; Abdel-Gadir A; Treibel TA; Banypersad SM; Maestrini V; Barcella W; Rosmini S; Bulluck H; Sayed RH; Patel K; Mamhood S; Bucciarelli-Ducci C; Whelan CJ; Herrey AS; Lachmann HJ; Wechalekar AD; Manisty CH; Schelbert EB; Kellman P; Gillmore JD; Hawkins PN; Moon JC
    Circulation; 2016 Mar; 133(12):e450-1. PubMed ID: 27002091
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement.
    Thomson LE
    J Am Coll Cardiol; 2008 Mar; 51(10):1031-2. PubMed ID: 18325443
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Fontana M; Pica S; Reant P; Abdel-Gadir A; Treibel TA; Banypersad SM; Maestrini V; Barcella W; Rosmini S; Bulluck H; Sayed RH; Patel K; Mamhood S; Bucciarelli-Ducci C; Whelan CJ; Herrey AS; Lachmann HJ; Wechalekar AD; Manisty CH; Schelbert EB; Kellman P; Gillmore JD; Hawkins PN; Moon JC
    Circulation; 2015 Oct; 132(16):1570-9. PubMed ID: 26362631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Magnetic Resonance Visualization of Cardiac Amyloid Infiltration: Challenges and Opportunities.
    Ruberg FL; Nezafat R
    Circulation; 2015 Oct; 132(16):1525-7. PubMed ID: 26362630
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
    Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
    J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal gadolinium kinetics in cardio MRI - always an indication of cardiac amyloidosis?].
    Baeßler B; Reuter H; Huntgeburth M; Bunck AC
    Rofo; 2015 Mar; 187(3):189-91. PubMed ID: 25184217
    [No Abstract]   [Full Text] [Related]  

  • 9. Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.
    Lyne JC; Petryka J; Pennell DJ
    Eur Heart J; 2008 Jan; 29(2):212. PubMed ID: 17704093
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function.
    Kwong RY; Heydari B; Abbasi S; Steel K; Al-Mallah M; Wu H; Falk RH
    Am J Cardiol; 2015 Aug; 116(4):622-9. PubMed ID: 26076990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenging Occam's Razor: An Unusual Combination of Sarcoidosis and Amyloidosis. The Value of Cardiac Magnetic Resonance Imaging in Infiltrative Cardiomyopathies.
    Nyktari E; Vassiliou VS; Arzanauskaite M; Gatehouse P; Greiser A; Wechalekar A; Gilbertson J; Pierce I; Sharma R; Mohiaddin R
    Can J Cardiol; 2017 Oct; 33(10):1335.e9-1335.e11. PubMed ID: 28870471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular magnetic resonance in cardiac amyloidosis.
    Maceira AM; Joshi J; Prasad SK; Moon JC; Perugini E; Harding I; Sheppard MN; Poole-Wilson PA; Hawkins PN; Pennell DJ
    Circulation; 2005 Jan; 111(2):186-93. PubMed ID: 15630027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR Imaging and Cardiac Amyloidosis Where to Go From Here?
    Selvanayagam JB; Leong DP
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):165-7. PubMed ID: 20159643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
    Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects.
    Krombach GA; Hahn C; Tomars M; Buecker A; Grawe A; Günther RW; Kühl HP
    J Magn Reson Imaging; 2007 Jun; 25(6):1283-7. PubMed ID: 17520735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
    Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of systolic and diastolic function in patients with LGE negative systemic amyloidosis using CMR.
    Kuetting DL; Homsi R; Sprinkart AM; Luetkens J; Thomas DK; Schild HH; Dabir D
    Int J Cardiol; 2017 Apr; 232():336-341. PubMed ID: 28153537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Cardiac MR Imaging in Cardiomyopathies.
    Kramer CM
    J Nucl Med; 2015 Jun; 56 Suppl 4(0 4):39S-45S. PubMed ID: 26033902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.